Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

NCT: NCT07503236 · NOT_YET_RECRUITING

NCT IDNCT07503236
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2032-12

Brief Summary

Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.

Frequently Asked Questions

What is Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System?

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System is a clinical trial registered under NCT07503236. Current status: NOT_YET_RECRUITING.

What is the status of NCT07503236?

The current status of NCT07503236 (Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System) is: NOT_YET_RECRUITING.

When did Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System start?

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑